These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20702688)

  • 1. SV2 regulates neurotransmitter release via multiple mechanisms.
    Nowack A; Yao J; Custer KL; Bajjalieh SM
    Am J Physiol Cell Physiol; 2010 Nov; 299(5):C960-7. PubMed ID: 20702688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cotrafficking of SV2 and synaptotagmin at the synapse.
    Yao J; Nowack A; Kensel-Hammes P; Gardner RG; Bajjalieh SM
    J Neurosci; 2010 Apr; 30(16):5569-78. PubMed ID: 20410110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam reverses synaptic deficits produced by overexpression of SV2A.
    Nowack A; Malarkey EB; Yao J; Bleckert A; Hill J; Bajjalieh SM
    PLoS One; 2011; 6(12):e29560. PubMed ID: 22220214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SV2A and SV2C contain a unique synaptotagmin-binding site.
    Schivell AE; Mochida S; Kensel-Hammes P; Custer KL; Bajjalieh SM
    Mol Cell Neurosci; 2005 May; 29(1):56-64. PubMed ID: 15866046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis.
    Chang WP; Südhof TC
    J Neurosci; 2009 Jan; 29(4):883-97. PubMed ID: 19176798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.
    Dong M; Liu H; Tepp WH; Johnson EA; Janz R; Chapman ER
    Mol Biol Cell; 2008 Dec; 19(12):5226-37. PubMed ID: 18815274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic vesicle protein 2 enhances release probability at quiescent synapses.
    Custer KL; Austin NS; Sullivan JM; Bajjalieh SM
    J Neurosci; 2006 Jan; 26(4):1303-13. PubMed ID: 16436618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A).
    Crowder KM; Gunther JM; Jones TA; Hale BD; Zhang HZ; Peterson MR; Scheller RH; Chavkin C; Bajjalieh SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15268-73. PubMed ID: 10611374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoform-specific, calcium-regulated interaction of the synaptic vesicle proteins SV2 and synaptotagmin.
    Schivell AE; Batchelor RH; Bajjalieh SM
    J Biol Chem; 1996 Nov; 271(44):27770-5. PubMed ID: 8910372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release.
    Janz R; Goda Y; Geppert M; Missler M; Südhof TC
    Neuron; 1999 Dec; 24(4):1003-16. PubMed ID: 10624962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses.
    Vogl C; Tanifuji S; Danis B; Daniels V; Foerch P; Wolff C; Whalley BJ; Mochida S; Stephens GJ
    Eur J Neurosci; 2015 Feb; 41(4):398-409. PubMed ID: 25484265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptotagmin I synchronizes transmitter release in mouse hippocampal neurons.
    Nishiki T; Augustine GJ
    J Neurosci; 2004 Jul; 24(27):6127-32. PubMed ID: 15240804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the SV2-like protein SVOP produces no apparent deficits in laboratory mice.
    Yao J; de la Iglesia HO; Bajjalieh SM
    PLoS One; 2013; 8(7):e68215. PubMed ID: 23894296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SV2 modulates the size of the readily releasable pool of secretory vesicles.
    Xu T; Bajjalieh SM
    Nat Cell Biol; 2001 Aug; 3(8):691-8. PubMed ID: 11483953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SV2 mediates entry of tetanus neurotoxin into central neurons.
    Yeh FL; Dong M; Yao J; Tepp WH; Lin G; Johnson EA; Chapman ER
    PLoS Pathog; 2010 Nov; 6(11):e1001207. PubMed ID: 21124874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SV2B regulates synaptotagmin 1 by direct interaction.
    Lazzell DR; Belizaire R; Thakur P; Sherry DM; Janz R
    J Biol Chem; 2004 Dec; 279(50):52124-31. PubMed ID: 15466855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SV2 is the protein receptor for botulinum neurotoxin A.
    Dong M; Yeh F; Tepp WH; Dean C; Johnson EA; Janz R; Chapman ER
    Science; 2006 Apr; 312(5773):592-6. PubMed ID: 16543415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SV2A controls the surface nanoclustering and endocytic recruitment of Syt1 during synaptic vesicle recycling.
    Small C; Harper C; Jiang A; Kontaxi C; Pronot M; Yak N; Malapaka A; Davenport EC; Wallis TP; Gormal RS; Joensuu M; Martínez-Mármol R; Cousin MA; Meunier FA
    J Neurochem; 2024 Sep; 168(9):3188-3208. PubMed ID: 39091022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylation is dispensable for sorting of synaptotagmin 1 but is critical for targeting of SV2 and synaptophysin to recycling synaptic vesicles.
    Kwon SE; Chapman ER
    J Biol Chem; 2012 Oct; 287(42):35658-35668. PubMed ID: 22908222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SV2 frustrating exocytosis at the semi-diffusor synapse.
    Vautrin J
    Synapse; 2009 Apr; 63(4):319-38. PubMed ID: 19140166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.